Kamada logo

Kamada Share Price Today

(NASDAQ: KMDA)

Kamada share price is $7.1 & ₹617.48 as on 6 Mar 2025, 2.30 'hrs' IST

$7.1

0.49

(7.41%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Kamada share price in Dollar and Rupees. Guide to invest in Kamada stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Kamada, along with analyst recommendations, forecasts, and comprehensive financials.

Kamada share price movements

  • Today's Low: $6.89
    Today's High: $7.24

    Day's Volatility :4.83%

  • 52 Weeks Low: $4.74
    52 Weeks High: $9.16

    52 Weeks Volatility :48.23%

Kamada (KMDA) Returns

PeriodKamada LtdSector (Health Care)Index (Russel 2000)
3 Months
10.17%
2.1%
0.0%
6 Months
20.18%
-4.1%
0.0%
1 Year
9.26%
2.2%
0.0%
3 Years
20.18%
11.8%
-11.6%

Kamada (KMDA) Key Statistics

in dollars & INR

Previous Close
$6.61
Open
$6.79
Today's High
$7.24
Today's Low
$6.89
Market Capitalization
$402.6M
Today's Volume
$26.2K
52 Week High
$9.155
52 Week Low
$4.74
Revenue TTM
$158.4M
EBITDA
$29.4M
Earnings Per Share (EPS)
$0.27
PE Ratio
25.15
Profit Margin
9.92%
Quarterly Earnings Growth YOY
0.17%
Return On Equity TTM
6.37%

How to invest in Kamada Stock (KMDA) from India?

It is very easy for Indian residents to invest directly in Kamada from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kamada stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kamada or KMDA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kamada or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kamada shares which would translate to 0.122 fractional shares of Kamada as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kamada, in just a few clicks!

Returns in Kamada (KMDA) for Indian investors in Rupees

The Kamada stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kamada investment value today

Current value as on today

₹1,22,318

Returns

₹22,318

(+22.32%)

Returns from Kamada Stock

₹17,355 (+17.36%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Kamada (KMDA)

243%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Kamada Stock from India on INDmoney has increased by 243% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Kamada

    Analyst Recommendation on Kamada

    Buy

      85%Buy

      14%Hold

      0%Sell

    Based on 7 Wall street analysts offering stock ratings for Kamada(by analysts ranked 0 to 5 stars)

    Based on 7 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    6
    6
    6
    Hold
    1
    1
    1
    Sell
    0
    0
    0

    Analyst Forecast on Kamada Stock (KMDA)

    What analysts predicted

    Upside of 100.7%

    Target:

    $14.25

    Current:

    $7.10

    Insights on Kamada Stock (Ticker Symbol: KMDA)

    • Price Movement

      In the last 3 months, KMDA stock has moved up by 10.2%
    • Decreasing Revenue

      Revenue is down for the last 2 quarters, 41.87M → 41.74M (in $), with an average decrease of 0.3% per quarter
    • Decreasing Net Profit

      Netprofit is down for the last 2 quarters, 4.42M → 3.86M (in $), with an average decrease of 12.7% per quarter
    • KMDA vs ITCI (1 yr)

      In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 93.2%
    • KMDA vs ITCI (3 yr)

      In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 119.5%
    • Price to Sales

      ForKMDA every $1 of sales, investors are willing to pay $2.4, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

    KMDA Kamada Financials in INR & Dollars

    FY18Y/Y Change
    Revenue
    $114.5M
    ↑ 11.32%
    Net Income
    $22.3M
    ↑ 223.08%
    Net Profit Margin
    19.48%
    ↑ 12.77%
    FY19Y/Y Change
    Revenue
    $127.2M
    ↑ 11.11%
    Net Income
    $22.3M
    ↓ 0.2%
    Net Profit Margin
    17.49%
    ↓ 1.99%
    FY20Y/Y Change
    Revenue
    $133.2M
    ↑ 4.76%
    Net Income
    $17.1M
    ↓ 22.97%
    Net Profit Margin
    12.86%
    ↓ 4.63%
    FY21Y/Y Change
    Revenue
    $103.6M
    ↓ 22.22%
    Net Income
    $-2.2M
    ↓ 113.01%
    Net Profit Margin
    -2.15%
    ↓ 15.01%
    FY22Y/Y Change
    Revenue
    $129.3M
    ↑ 24.79%
    Net Income
    $-2.3M
    ↑ 4.08%
    Net Profit Margin
    -1.79%
    ↑ 0.36%
    FY23Y/Y Change
    Revenue
    $142.5M
    ↑ 10.19%
    Net Income
    $8.3M
    ↓ 456.92%
    Net Profit Margin
    5.81%
    ↑ 7.6%
    Q2 FY23Q/Q Change
    Revenue
    $37.4M
    ↑ 0.0%
    Net Income
    $1.8M
    ↑ 0.0%
    Net Profit Margin
    4.84%
    ↑ 0.0%
    Q3 FY23Q/Q Change
    Revenue
    $37.9M
    ↑ 1.31%
    Net Income
    $3.2M
    ↑ 77.87%
    Net Profit Margin
    8.5%
    ↑ 3.66%
    Q4 FY23Q/Q Change
    Revenue
    $37.4M
    ↓ 1.41%
    Net Income
    $2.4M
    ↓ 26.62%
    Net Profit Margin
    6.32%
    ↓ 2.18%
    Q1 FY24Q/Q Change
    Revenue
    $37.7M
    ↑ 0.9%
    Net Income
    $2.4M
    ↑ 0.0%
    Net Profit Margin
    6.27%
    ↓ 0.05%
    Q2 FY24Q/Q Change
    Revenue
    $41.9M
    ↑ 10.97%
    Net Income
    $4.4M
    ↑ 87.15%
    Net Profit Margin
    10.57%
    ↑ 4.3%
    Q3 FY24Q/Q Change
    Revenue
    $41.7M
    ↓ 0.33%
    Net Income
    $3.9M
    ↓ 12.72%
    Net Profit Margin
    9.25%
    ↓ 1.32%
    FY18Y/Y Change
    Profit
    $41.5M
    ↑ 29.24%
    FY19Y/Y Change
    Profit
    $49.7M
    ↑ 19.93%
    FY20Y/Y Change
    Profit
    $47.6M
    ↓ 4.39%
    FY21Y/Y Change
    Profit
    $30.3M
    ↓ 36.22%
    FY22Y/Y Change
    Profit
    $46.7M
    ↑ 53.99%
    FY23Y/Y Change
    Profit
    $55.5M
    ↑ 18.81%
    Q2 FY23Q/Q Change
    Profit
    $14.4M
    ↑ 0.0%
    Q3 FY23Q/Q Change
    Profit
    $14.8M
    ↑ 2.54%
    Q4 FY23Q/Q Change
    Profit
    $16.6M
    ↑ 12.15%
    Q1 FY24Q/Q Change
    Profit
    $16.8M
    ↑ 0.9%
    Q2 FY24Q/Q Change
    Profit
    $18.7M
    ↑ 11.55%
    Q3 FY24Q/Q Change
    Profit
    $17.2M
    ↓ 7.77%
    FY18Y/Y Change
    Operating Cash Flow
    $10.5M
    ↑ 171.11%
    Investing Cash Flow
    $-5.2M
    ↓ 66.84%
    Financing Cash Flow
    $-587.0K
    ↓ 103.83%
    FY19Y/Y Change
    Operating Cash Flow
    $27.6M
    ↑ 161.44%
    Investing Cash Flow
    $-564.0K
    ↓ 89.1%
    Financing Cash Flow
    $-1.5M
    ↑ 160.65%
    FY20Y/Y Change
    Operating Cash Flow
    $19.1M
    ↓ 30.71%
    Investing Cash Flow
    $-13.1M
    ↑ 2227.48%
    Financing Cash Flow
    $23.4M
    ↓ 1627.06%
    FY21Y/Y Change
    Operating Cash Flow
    $-8.8M
    ↓ 146.16%
    Investing Cash Flow
    $-61.1M
    ↑ 365.07%
    Financing Cash Flow
    $18.6M
    ↓ 20.42%
    FY22Y/Y Change
    Operating Cash Flow
    $28.6M
    ↓ 424.14%
    Investing Cash Flow
    $-3.8M
    ↓ 93.8%
    Financing Cash Flow
    $-9.3M
    ↓ 150.25%
    Q2 FY23Q/Q Change
    Operating Cash Flow
    $1.8M
    ↑ 0.0%
    Investing Cash Flow
    $-1.0M
    ↓ 2.1%
    Financing Cash Flow
    $-5.9M
    ↑ 0.0%
    Q3 FY23Q/Q Change
    Operating Cash Flow
    $921.0K
    ↓ 49.34%
    Investing Cash Flow
    $-1.7M
    ↑ 64.98%
    Financing Cash Flow
    $31.3M
    ↓ 634.5%

    Kamada Technicals Summary

    Sell

    Neutral

    Buy

    Kamada is currently in a neutral trading position according to technical analysis indicators.

    Kamada (KMDA) Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Kamada Ltd logo
    -2.22%
    20.18%
    9.26%
    20.18%
    23.55%
    Intra-cellular Therapies, Inc. logo
    3.42%
    81.22%
    98.76%
    146.55%
    588.92%
    Haleon Plc Spon Ads logo
    12.55%
    3.39%
    28.09%
    43.99%
    43.99%
    Zoetis Inc. logo
    -1.19%
    -8.94%
    -7.43%
    -9.67%
    30.97%
    Neurocrine Biosciences Inc. logo
    -24.64%
    -6.68%
    -14.47%
    28.61%
    27.88%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Kamada Ltd logo
    25.15
    25.15
    8.75
    0.24
    0.06
    0.03
    NA
    4.63
    Intra-cellular Therapies, Inc. logo
    NA
    NA
    0.0
    0.13
    -0.09
    -0.07
    NA
    10.81
    Haleon Plc Spon Ads logo
    26.68
    26.68
    1.5
    0.36
    0.09
    0.04
    0.02
    1.8
    Zoetis Inc. logo
    31.17
    31.17
    3.01
    6.07
    0.51
    0.15
    0.01
    10.64
    Neurocrine Biosciences Inc. logo
    34.8
    34.8
    0.27
    6.47
    0.14
    0.1
    NA
    26.05
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Kamada Ltd logo
    Buy
    $402.6M
    23.55%
    25.15
    9.92%
    Intra-cellular Therapies, Inc. logo
    Buy
    $14.0B
    588.92%
    NA
    -10.97%
    Haleon Plc Spon Ads logo
    Buy
    $48.2B
    43.99%
    26.68
    12.84%
    Zoetis Inc. logo
    Buy
    $76.1B
    30.97%
    31.17
    26.86%
    Neurocrine Biosciences Inc. logo
    Buy
    $11.3B
    27.88%
    34.8
    14.49%

    About Kamada

    Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
    Organization
    Kamada
    Employees
    378
    CEO
    Mr. Amir London
    Industry
    Health Technology

    Management People of Kamada

    NameTitle
    Mr. Amir London
    Chief Executive Officer
    Mr. Chaime Orlev
    Chief Financial Officer
    Mr. Eran Nir
    Chief Operating Officer
    Mr. Jon R. Knight
    Vice President of US Commercial Operations
    Mr. Boris Gorelik
    Vice President of Business Development & Strategic Programs
    Mr. David Tsur
    Co-Founder & Independent Deputy Chairman of the Board
    Mr. Nir Livneh B.A., L.L.B.
    VP, General Counsel & Corporate Secretary
    Ms. Hanni Neheman
    Vice President of Marketing & Sales
    Ms. Liron Reshef
    Vice President of Human Resources
    Ms. Shavit Beladev
    Vice President of Kamada Plasma

    Important FAQs about investing in KMDA Stock from India :

    What is Kamada share price today?

    Kamada share price today stands at $7.10, Open: $6.79 ; Previous Close: $6.61 ; High: $7.24 ; Low: $6.89 ; 52 Week High: $9.16 ; 52 Week Low: $4.74.

    The stock opens at $6.79, after a previous close of $6.61. The stock reached a daily high of $7.24 and a low of $6.89, with a 52-week high of $9.16 and a 52-week low of $4.74.

    Can Indians buy Kamada shares?

    Yes, Indians can invest in the Kamada (KMDA) from India.

    With INDmoney, you can buy Kamada at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Kamada at zero transaction cost.

    How can I buy Kamada shares from India?

    It is very easy to buy Kamada from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Kamada (KMDA) be purchased?

    Yes, you can buy fractional shares of Kamada with INDmoney app.

    What are the documents required to start investing in Kamada stocks?

    To start investing in Kamada, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Kamada Stock (KMDA)?

    Today’s highest price of Kamada (KMDA) is $7.24.

    Today’s lowest price of Kamada (KMDA) is $6.89.

    What is today's market capitalisation of Kamada?

    Today's market capitalisation of Kamada KMDA is 402.6M

    What is the 52 Week High and Low Range of Kamada Stock (KMDA)?

    • 52 Week High

      $9.16

    • 52 Week Low

      $4.74

    What are the historical returns of Kamada (KMDA)?

    • 1 Month Returns

      -2.22%

    • 3 Months Returns

      20.18%

    • 1 Year Returns

      9.26%

    • 5 Years Returns

      23.55%

    Who is the Chief Executive Officer (CEO) of Kamada ?

    Mr. Amir London is the current Chief Executive Officer (CEO) of Kamada.